Zhongjin: Trump enters a new stage of trade deal.
Products face pressure in both scenarios of out-of-control inflation and economic slowdown, and it is suggested to maintain a low configuration.
Performance is good, but this pattern may not apply to the inflation caused by Trump's policies. The reason is that the current inflation pressure is caused by "artificial inflation" from policies such as tariffs and immigration, rather than "natural inflation" formed by the normal operation of the economic cycle. During the inflation phase, there is no expansion of commodity demand. On the contrary, in order to hedge against the negative impact of inflation on the economy, the Trump administration may take more forceful measures to suppress commodity prices. Therefore, commodities face pressure in both scenarios of uncontrollable inflation and economic slowdown, and it is recommended to maintain a low allocation."Hola, cmo ests?"
Translated to
"Hello, how are you?"
Related Articles

Infotmic Co., Ltd. shareholder Orient intends to reduce its shareholding by no more than 3%.

US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.

US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.
Infotmic Co., Ltd. shareholder Orient intends to reduce its shareholding by no more than 3%.

US Stock Market Move | Palantir (PLTR.US) fell more than 6.7% in response to its impressive Q3 financial report, but the market is concerned that its valuation is too high.

US Stock Market Move | Royal Philips N.V. Sponsored ADR (PHG.US) rises 3% in Q3, adjusted EBITA exceeds expectations.

RECOMMEND

World’s largest oil company Aramco posts higher Q3 net profit after lifting output
04/11/2025

HSBC, General Atlantic CEOs flag AI capex-revenue mismatch, ‘irrational exuberance’
04/11/2025

Pfizer Files Second Lawsuit Against Novo Nordisk and Metsera Amid Intensifying Bidding Battle Over Obesity Biotech
04/11/2025


